EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects

Jesús I Gil-Chinchilla iD, Agustín G Zapata, Jose M Moraleda iD, David García-Bernal iD

Biomolecules · 2024

DOI: 10.3390/biom14070734 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Jesús I Gil-Chinchilla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria (IMIB) Pascual Parrilla, Virgen de la Arrixaca U…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Neoplasms, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 233 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, ERDF-Next Generation EU “Plan de Recuperación, Transformación y Resiliencia”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stem/stromal cells (MSCs) are one of the most widely used cell types in advanced therapies due to their therapeutic potential in the regulation of tissue repair and homeostasis, and immune modulation. However, their use in cancer therapy is controversial: they can inhibit cancer cell proliferation, but also potentially promote tumour growth by supporting angiogenesis, modulation of the immune milieu and increasing cancer stem cell invasiveness. This opposite behaviour highlights the need for careful and nuanced use of MSCs in cancer treatment. To optimize their anti-cancer effects, diverse strategies have bioengineered MSCs to enhance their tumour targeting and therapeutic properties or to deliver anti-cancer drugs. In this review, we highlight the advanced uses of MSCs in cancer therapy, particularly as carriers of targeted treatments due to their natural tumour-homing capabilities. We also discuss the potential of MSC-derived extracellular vesicles to improve the efficiency of drug or molecule delivery to cancer cells. Ongoing clinical trials are evaluating the therapeutic potential of these cells and setting the stage for future advances in MSC-based cancer treatment. It is critical to identify the broad and potent applications of bioengineered MSCs in solid tumour targeting and anti-cancer agent delivery to position them as effective therapeutics in the evolving field of cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsNeoplasmsMesenchymal Stem Cell TransplantationHumansAnimalsBioengineeringAntineoplastic AgentsExtracellular VesiclesDrug Delivery Systems

Stichwörter der Autor:innen

anti-cancer therapycell therapymesenchymal stem/stromal cellstargeted therapytherapeutic vehicles

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria (IMIB) Pascual Parrilla, Virgen de la Arrixaca University Hospital, University of Murcia, 30120 Murcia, Spain.
  • Department of Cell Biology, Complutense University, 28040 Madrid, Spain.
  • Department of Medicine, University of Murcia, 30120 Murcia, Spain.
  • Department of Biochemistry, Molecular Biology and Immunology, University of Murcia, 30120 Murcia, Spain.

ORCID-Profile: Jesús I Gil-Chinchilla, Jose M Moraleda, David García-Bernal

Förderung

  • Instituto de Salud Carlos III
  • ERDF-Next Generation EU “Plan de Recuperación, Transformación y Resiliencia”

Zitieren

APA

Gil-Chinchilla, J. I., Zapata, A. G., Moraleda, J. M., & García-Bernal, D. (2024). Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects. Biomolecules. https://doi.org/10.3390/biom14070734

Vancouver

Gil-Chinchilla JI, Zapata AG, Moraleda JM, García-Bernal D. Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects. Biomolecules. 2024. doi:10.3390/biom14070734

BibTeX
@article{GilChinchilla2024,
  author = {Gil-Chinchilla, Jesús I and Zapata, Agustín G and Moraleda, Jose M and García-Bernal, David},
  title = {Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14070734}
}
Kostenlos starten →